This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Erythrocytosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Traditionally, polycythaemia describes a group of varied disorders with an increase in the number of circulating red cells above established normal limits (erythrocytosis is the appropriate term since only the red cell lineage is involved in the disease) (1).

Age, sex, nutritional status and residential altitude all contribute to natural variations. As a guideline, erythrocytosis should be suspected when there is persistently raised venous haematocrit (Hct) (>0.52 males, >0.48 females for > 2 months) or haemoglobin (in men greater than 18.0 g per L or in women with values greater than 17.0 g per L) (1).

The increased blood viscosity associated with polycythaemia increases the risk of thrombotic complications.

Erythrocytosis can be:

  • absolute – both haematocrit (Hct) level and red cell mass are elevated
  • apparent – people with raised venous haematocrit (Hct) but with a red cell mass withinreference range

True increased red cell mass (rather than apparent erythrocytosis) can be assumed when the haematocrit is over 60% in males and 56% in females (2)

Note that normal ranges vary with different commercial kits.

A schemata for considering polycythaemia in adults is presented (3):

 

Reference:


Related pages

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.